Tammy Wheeler
Psychiatric/Mental Health · Hilo, HINPI 1124193537
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.0% of the total across 169 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 18.9% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in HI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 169 payments — averaging $29.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$933
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$758
- AbbVie$742
- Neurocrine Biosciences, Inc.$650
- Teva Pharmaceuticals USA, Inc.$535
- Lundbeck LLC$338
- plus $982 from 7 others
What the payments were for
- Food & beverage$4,83998%
- Education$1002%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 41 | $933 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 23 | $758 |
| AbbVie | 33 | $742 |
| Neurocrine Biosciences, Inc. | 14 | $650 |
| Teva Pharmaceuticals USA, Inc. | 12 | $535 |
| Lundbeck LLC | 14 | $338 |
| Indivior Inc. | 6 | $315 |
| Otsuka America Pharmaceutical, Inc. | 11 | $282 |
| Sunovion Pharmaceuticals Inc. | 9 | $149 |
| Johnson & Johnson | 3 | $136 |
| E.r. Squibb & Sons, L.L.C. | 1 | $43 |
| Vanda Pharmaceuticals Inc. | 1 | $30 |
| Axsome Therapeutics, Inc. | 1 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$520
- CAPLYTA$138
- INGREZZA$125
- Austedo XR$121
- ABILIFY MAINTENA$106
- ABILIFY ASIMTUFII$106
- VRAYLAR$101
How this compares
$4,939 in reported general payments places this provider in the 90th percentile of 103 psychiatric/mental health providers in Hawaii.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 89 | $198,431 |
| RexultiBrexpiprazole | 28 | $44,417 |
| VraylarCariprazine Hcl | 27 | $42,204 |
| FanaptIloperidone | 16 | $25,888 |
| Lurasidone Hcl | 13 | $13,850 |
| Divalproex Sodium ErDivalproex Sodium | 44 | $2,813 |
| Aripiprazole | 27 | $2,724 |
| Haloperidol Decanoate | 34 | $2,254 |
| Olanzapine | 95 | $2,247 |
| Olanzapine OdtOlanzapine | 12 | $1,588 |
| Risperidone | 25 | $1,291 |
| Clozapine | 13 | $1,182 |
| Benztropine Mesylate | 49 | $819 |
| Escitalopram Oxalate | 25 | $814 |
| Trazodone Hcl | 42 | $813 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna | $136 | $198,43189 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $282 | $44,41728 claims |
| AbbVieVraylar | $742 | $42,20427 claims |
| Vanda Pharmaceuticals Inc.Fanapt | $30 | $25,88816 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 103 psychiatric/mental health providers in Hawaii.
Other psychiatric/mental health in Hilo
- Melissa GarnettHilo$6K
- Allen NovakHilo$3K
- Ryan GarnettHilo$2K
- Julie AgnoHilo$907
- Tracy ThornettHilo$806
- Beth Ananda-StoutHilo$408
- J D BrandmanHonolulu$63K
- Jeremy CreekmoreAiea$13K
- Kuuleikuponookealoha NaahieluaAiea$8K
- Jacqueline WernerKapolei$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.